Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) for the reporting period ending March 6, 2017. The filing reports the termination of a rights offering to shareholders.
Key Financial Metrics
- Gross Proceeds: Approximately $20.1 million from the sale of approximately 13.7 million units.
- Unit Price: $1.47 per unit.
- Unit Composition: One share and one immediately exercisable five-year warrant with a strike price of $1.47.
- Expected Net Proceeds: Approximately $19.7 million.
- Other Metrics: The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity beyond the proceeds from this specific offering.
Material Changes
The primary material event is the completion of an oversubscribed rights offering. The company raised approximately $20.1 million in gross capital, significantly increasing its cash position relative to the pre-offering state, though specific prior period comparisons are not detailed in this text.
Guidance, Outlook, and Risks
Management indicated the offering was oversubscribed. The filing incorporates by reference a press release dated March 9, 2017, regarding the completion of the offering. No specific forward-looking guidance, risk factors, or contingencies are detailed within the text of this specific 8-K filing.
Investor Verification Checklist
- Verify the exact number of units sold and final net proceeds after deducting offering expenses.
- Confirm the dilution impact of the 13.7 million new shares and associated warrants on existing shareholders.
- Review the incorporated Exhibit 99.1 (Press Release) for additional details on the use of proceeds.
- Check subsequent filings for the actual cash balance post-offering to confirm the $19.7 million net proceeds estimate.